To ask the Scottish Executive what plans it has to liaise with the Medicine Control Agency and the Gene Therapy Advisory Committee to ensure (a) the continuation of the research into solid tumour treatments being conducted by Professor Moira Brown of Glasgow University and (b) that a phase one trial for encolytic virus therapy for mesothelioma is conducted in Scotland. None. However, the Scottish Executive continues to be informed, and to have the opportunity to comment if it so wishes, about the work of the Medicine Control Agency and the Gene Therapy Advisory Committee, both of which are non-devolved bodies whose work includes the approval of research proposals on a UK basis that involve genetic manipulation in terms of human therapy.The Scottish Executive is currently funding (to the total value of £253k) two projects on treatments for solid tumours where Professor Moira Brown is one of the researchers: one focuses on melanoma and the other on brain tumours using a mutant Herpes simplex virus.